Table 1: Baseline Patient Characteristics

With Baseline 135 Mutation Without Baseline 135 Mutation p-Value
N
Gender
      Male (%)
      Female (%)
Age (years)
      Mean
      SD
CD4 (cells/mm3)
      Median
      Q1 – Q3
Viral load (copies/mL)
      Median
      Q1 – Q3
Follow-up period (months)
      Median
      Q1 – Q3
Regimen based on
      Nevirapine (%)
      Efavirenz (%)
      Delavirdine (%)

RT mutations (%)

Naïve to antiretrovirals (%)		 30

19 (63%)
11 (37%)

45.7
9.4

190
130 - 270

81,350
32,700 - >100,000

15.7
5.0-37.2

23 (77%)
6 (20%)
1 (3%)

3 (10%)

14 (47%)		 38

25 (66%)
13 (34%)

39.2
7.1

190
110 - 270

65,800
26,780 - >100,000

14.2
5.4-21.6

32 (84%)
5 (13%)
1 (3%)

3 (8%)

21 (55%)

0.99


0.003


0.99


0.44


0.50


0.76



0.99

0.63

Note: Q1 indicates first quartile; Q3 third interquartile; RT indicates reverse transcriptase; SD indicates standard deviation.